• 

  Rank Hit by £6.2m Fraud

• 

  Abivax Shares Soar on Reports of Eli Lilly Engagement with French Officials

• 

  UK Market Trends: Oracle and GSK

• 

  Navigating European Markets: UK Growth Steady in Q3, Saipem on the Rise

• 

  Capital Gains Tax: £30bn Investor Nightmare

• 

  UK Markets Surge as Tech Fuels Gains

• 

  Roche’s Lunsumio VELO Gains FDA Accelerated Approval for Lymphoma

• 

  Saipem Shares Rally Following Landmark $3.1 Billion QatarEnergy LNG Contract Win

• 

  Emerging Markets Shine

• 

  Pound Cost Averaging: Invest Wisely

• 

  FTSE 100 Bargain Hunting

• 

  Flight Delays: No Compensation

• 

  Japanese Equities Surge: Nikkei 225 Climbs as Market Optimism Takes Hold

• 

  UK Billionaires Ranked by Wealth

• 

  UK Firms Lose £80m in Bitcoin

• 

  UK Car Industry Misses Net Zero Targets

• 

  Binance’s Ongoing Compliance Struggle: Unchecked Crypto Flows Post-US Deal

• 

  JP Morgan’s 2026 Outlook: Leading US Large-Cap Pharmaceutical Stocks Analysed

• 

  London House Prices 2025

• 

  Australian Equities Surge: S&P/ASX 200 Climbs 0.91%